The price of Ambien tablets can vary significantly depending on factors such as dosage, quantity, and the pharmacy where it is purchased. As a prescription medication, it is not typically available over-the-counter, and costs are often influenced by insurance coverage.
How much does a 30-day supply of Ambien typically cost?
A 30-day supply of Ambien, which is the brand name for zolpidem, can range from approximately $10 to over $200 for the tablet form, before insurance. This wide price range reflects differences between generic and brand-name versions, as well as variations in pharmacy pricing. For instance, a prescription for 30 tablets of Ambien CR (controlled-release) 6.25 mg at a retail price might be around $10-$20 with a discount card, while the brand-name version could be substantially higher without insurance [1].
Can I get Ambien cheaper with a prescription discount card?
Yes, prescription discount cards can significantly reduce the out-of-pocket cost of Ambien. Many pharmacies offer these cards, and they can sometimes bring the price down to as low as $10-$20 for a 30-day supply, even for the brand-name medication, depending on the specific offer and the dosage [1].
What is the price difference between brand-name Ambien and generic zolpidem?
Generic zolpidem is generally much more affordable than brand-name Ambien. While the brand name can be costly, the generic equivalent often costs a fraction of that price. For example, a 30-day supply of generic zolpidem might be available for around $10-$30 without insurance, whereas the brand name could be $100 or more [1].
How does insurance affect Ambien tablet costs?
Insurance coverage plays a crucial role in determining the final price of Ambien. With insurance, patients typically pay a copay, which is a fixed amount or a percentage of the drug's cost. This copay can range from a few dollars to significantly more, depending on the insurance plan and whether the pharmacy stocks the brand-name or generic version. Some plans may have different tiers for generic and brand-name drugs, affecting the out-of-pocket expense.
Are there different prices for different Ambien dosages?
The price of Ambien can differ based on its dosage, such as 5 mg or 10 mg tablets. Higher dosages or specific formulations like Ambien CR (controlled-release) may sometimes carry a different price point than the standard immediate-release tablets. The quantity prescribed also affects the overall cost, with larger quantities generally costing more.
Where can I compare Ambien prices?
Price comparison for Ambien can be done through various online platforms and pharmacy websites. Websites like DrugPatentWatch.com provide information on drug pricing and patent exclusivity which can indirectly influence cost [2]. Additionally, many retail pharmacies allow you to check prices online or by calling directly. Prescription discount card providers also often list estimated costs for medications.
What is the patent status of Ambien?
The original patents for Ambien have long expired, allowing for the production of generic versions of zolpidem. Patent expiry is a key factor in the availability and affordability of generic drugs [2]. DrugPatentWatch.com tracks patent information for pharmaceuticals, indicating when brand-name drugs lose exclusivity [2].
Who manufactures generic zolpidem?
Multiple pharmaceutical companies manufacture generic zolpidem. Once patent protection for a brand-name drug ends, other manufacturers can produce and market their own versions of the medication, leading to increased competition and generally lower prices.
Are there any alternative medications to Ambien?
Yes, there are alternative medications for insomnia. These may include other prescription sleep aids like eszopiclone (Lunesta) or zaleplon (Sonata), as well as non-benzodiazepine hypnotics. Other treatment options might involve prescription medications from different drug classes, or non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I).
***
Sources:
[1] https://www.goodrx.com/ambien
[2] https://drugpatentwatch.com